Clinical Trial Update: A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on insulin glargine U300 (Toujeo) evaluating efficacy and safety in Chinese adults with uncontrolled type 2 diabetes, including a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TOUJEO (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED